Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 30;13(2):469.
doi: 10.3390/nu13020469.

Systematic Review of Nutrition Supplements in Chronic Kidney Diseases: A GRADE Approach

Affiliations

Systematic Review of Nutrition Supplements in Chronic Kidney Diseases: A GRADE Approach

Pei-Chin Lin et al. Nutrients. .

Abstract

Chronic kidney disease (CKD) is cumulative worldwide and an increasing public health issue. Aside from the widely known protein restriction and medical therapy, less evident is the renal protection of nutrition supplements in CKD patients. This systematic review (SR), using a Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, aims to summarize and quantify evidence about the prevention effects of vitamin D and analogues, omega-3 polyunsaturated fatty acid (omega-3 PUFA), dietary fiber, coenzyme Q10 (CoQ10), and biotics on CKD progression. This study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement to examine SRs and/or meta-analysis of clinical controlled trials identified from PubMed, Embase, and the Cochrane Library. Finally, seventeen SRs were included in the qualitative analysis. The beneficial effects of these nutrition supplements in CKD patients mostly seem to be at low to very low evidence on proteinuria, kidney function, and inflammations and did not appear to improve CKD prognosis. The recommendation of nutrition supplements in CKD patients needs to discuss with physicians and consider the benefits over the adverse effects. Longer follow-up of larger randomized trials is necessary to clarify the benefits of nutrition supplements in CKD patients.

Keywords: biotics; chronic kidney disease; coenzyme Q10; dietary fiber; omega-3 polyunsaturated fatty acid; vitamin D and analogues.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram of including systematic reviews in this study [28].

References

    1. Van Dijk P.C., Jager K.J., Stengel B., Gronhagen-Riska C., Feest T.G., Briggs J.D. Renal replacement therapy for diabetic end-stage renal disease: Data from 10 registries in Europe (1991–2000) Kidney Int. 2005;67:1489–1499. doi: 10.1111/j.1523-1755.2005.00227.x. - DOI - PubMed
    1. Robinson B.M., Akizawa T., Jager K.J., Kerr P.G., Saran R., Pisoni R.L. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: Differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet. 2016;388:294–306. doi: 10.1016/S0140-6736(16)30448-2. - DOI - PMC - PubMed
    1. Caskey F.J., Kramer A., Elliott R.F., Stel V.S., Covic A., Cusumano A., Geue C., Macleod A.M., Zwinderman A.H., Stengel B., et al. Global variation in renal replacement therapy for end-stage renal disease. Nephrol. Dial. Transplant. 2011;26:2604–2610. doi: 10.1093/ndt/gfq781. - DOI - PubMed
    1. Ritz E., Orth S.R. Nephropathy in patients with type 2 diabetes mellitus. N. Engl. J. Med. 1999;341:1127–1133. doi: 10.1056/NEJM199910073411506. - DOI - PubMed
    1. Peralta C.A., Norris K.C., Li S., Chang T.I., Tamura M.K., Jolly S.E., Bakris G., McCullough P.A., Shlipak M., KEEP investigators Blood pressure components and end-stage renal disease in persons with chronic kidney disease: The Kidney Early Evaluation Program (KEEP) Arch. Intern. Med. 2012;172:41–47. doi: 10.1001/archinternmed.2011.619. - DOI - PMC - PubMed

Publication types

MeSH terms